BRPI0813735A2 - Compostos neuroesteróides - Google Patents

Compostos neuroesteróides

Info

Publication number: BRPI0813735A2
Authority: BR; Brazil
Prior art keywords: neurosteroid; compounds; neurosteroid compounds
Prior art date: 2007-06-20

Application number

BRPI0813735-8A2A

Other languages

English (en)

Inventor

Achilleas Gravanis

Theodora Calogeropoulou

Elias Castanas

Andreas Margioris

Ioannis Charalambopoulos

Nikolaos Avlonitis

Vassilios Minas

Vasileia-Ismini Alexaki

Christos Tsatsanis

Michael N Alexis

Eumorphia Remboutsika

Varvara Vergou

Constantinos Neophytou

Original Assignee

Bionature E A Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-20

Filing date

2008-06-17

Publication date

2014-12-30

2008-06-17 Application filed by Bionature E A Ltd filed Critical Bionature E A Ltd

2014-12-30 Publication of BRPI0813735A2 publication Critical patent/BRPI0813735A2/pt

Links

150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Virology (AREA)
Cardiology (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Communicable Diseases (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)

BRPI0813735-8A2A 2007-06-20 2008-06-17 Compostos neuroesteróides BRPI0813735A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0711948.0A GB0711948D0 (en)	2007-06-20	2007-06-20	Neurosteriod compounds
PCT/GB2008/002067 WO2008155534A2 (en)	2007-06-20	2008-06-17	Neurosteroid compounds

Publications (1)

Publication Number	Publication Date
BRPI0813735A2 true BRPI0813735A2 (pt)	2014-12-30

Family

ID=38352591

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0813735-8A2A BRPI0813735A2 (pt)	2007-06-20	2008-06-17	Compostos neuroesteróides

Country Status (14)

Country	Link
US (1)	US9777037B2 (pt)
EP (1)	EP2158209B1 (pt)
JP (1)	JP5698974B2 (pt)
KR (1)	KR101579323B1 (pt)
CN (1)	CN101784558B (pt)
AU (1)	AU2008265046C1 (pt)
BR (1)	BRPI0813735A2 (pt)
CA (1)	CA2691071C (pt)
EA (1)	EA018632B1 (pt)
GB (1)	GB0711948D0 (pt)
IL (1)	IL202223B (pt)
MX (2)	MX2009013189A (pt)
WO (1)	WO2008155534A2 (pt)
ZA (1)	ZA200908215B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102711769A (zh) *	2009-09-11	2012-10-03	生态自然E·A有限公司	甾体化合物在炎性和自身免疫疾病中的应用
CN101884638B (zh)	2010-07-09	2011-11-09	中山大学	5α-雄甾(烷)-3β,5,6β-三醇在制备神经元保护药物中的应用
US9388210B2 (en) *	2011-02-25	2016-07-12	Washington University	Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
WO2013043985A1 (en) *	2011-09-23	2013-03-28	The Regents Of The University Of California	Edible oils to enhance delivery of orally administered steroids
EP3572417B1 (en)	2011-10-14	2025-12-17	Sage Therapeutics, LLC	3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
EP2806877B2 (en)	2012-01-23	2025-01-29	Sage Therapeutics, Inc.	Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin
US20140050789A1 (en)	2012-08-13	2014-02-20	The Regents Of The University Of California	Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
CA2882708A1 (en)	2012-08-21	2014-02-27	Sage Therapeutics, Inc.	Methods of treating epilepsy or status epilepticus
AU2013352141B2 (en)	2012-11-30	2018-04-05	The Regents Of The University Of California	Anticonvulsant activity of steroids
HUE039057T2 (hu)	2012-12-18	2018-12-28	Univ Washington	Kezelési eljárásokban alkalmazható neuroaktív 19-alkoxi-17-szubsztituált szteroidok
US9512170B2 (en)	2013-03-01	2016-12-06	Washington University	Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en)	2013-03-11	2016-06-14	Washington University	Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en)	2013-03-14	2017-02-07	Washington University	Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
US20160068563A1 (en)	2013-04-17	2016-03-10	Boyd L. Harrison	19-nor neuroactive steroids and methods of use thereof
KR102396328B1 (ko)	2013-04-17	2022-05-10	세이지 테라퓨틱스, 인크.	19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
US9725481B2 (en)	2013-04-17	2017-08-08	Sage Therapeutics, Inc.	19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
EP2986624B1 (en)	2013-04-17	2020-03-25	Sage Therapeutics, Inc.	19-nor neuroactive steroids for methods of treatment
CN103275070A (zh) *	2013-05-10	2013-09-04	郑彪	调节单核细胞增殖的四环化合物及其应用
SI3021852T1 (sl)	2013-07-19	2021-07-30	Sage Therapeutics, Inc.	Nevroaktivni steroidi, sestavki in uporabe le-teh
AU2014308621C1 (en)	2013-08-23	2022-01-06	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
RU2684616C2 (ru) *	2014-01-29	2019-04-10	Умекрин Когнишн Аб	Стероидное соединение для применения в лечении печеночной энцефалопатии
US10246482B2 (en)	2014-06-18	2019-04-02	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar)	2014-09-08	2017-06-16	Sage Therapeutics Inc	سترويدات وتركيبات نشطة عصبياً، واستخداماتها
ME03809B (me)	2014-10-16	2021-04-20	Sage Therapeutics Inc	KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
CN117024501A (zh)	2014-10-16	2023-11-10	萨奇治疗股份有限公司	靶向cns障碍的组合物和方法
WO2016082789A1 (en)	2014-11-27	2016-06-02	Sage Therapeutics, Inc.	Compositions and methods for treating cns disorders
AR103384A1 (es)	2015-01-12	2017-05-03	Umecrine Cognition Ab	3a-ETINILO, 3b-HIDROXI, 5a-PREGNAN-20-OXIMA COMO MODULADOR DE GABA
RS61530B1 (sr)	2015-01-26	2021-04-29	Sage Therapeutics Inc	Kompozicije i postupci za lečenje poremećaja cns
EP4155314A1 (en)	2015-02-20	2023-03-29	Sage Therapeutics, Inc.	Neuroactive steroids, compositions, and uses thereof
KR20240157128A (ko)	2016-03-08	2024-10-31	세이지 테라퓨틱스, 인크.	신경활성 스테로이드, 조성물, 및 그의 용도
MA45599A (fr)	2016-07-11	2019-05-15	Sage Therapeutics Inc	Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
WO2018013615A1 (en)	2016-07-11	2018-01-18	Sage Therapeutics, Inc.	C7, c12, and c16 substituted neuroactive steroids and their methods of use
CN115651054B (zh)	2019-01-08	2024-06-21	成都康弘药业集团股份有限公司	甾体类化合物、用途及其制备方法
MX2021013695A (es)	2019-05-10	2022-01-26	Brii Biosciences Inc	Composición farmacéutica que contiene brexanolona, ganaxolona y zuranolona y usos de esta.
SG11202112391UA (en)	2019-05-31	2021-12-30	Sage Therapeutics Inc	Neuroactive steroids and compositions thereof
RU2750639C1 (ru) *	2021-04-27	2021-06-30	ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ НАУКИ ИНСТИТУТ ОРГАНИЧЕСКОЙ ХИМИИ им. Н.Д. ЗЕЛИНСКОГО РОССИЙСКОЙ АКАДЕМИИ НАУК (ИОХ РАН)	Замещенные спироандростен-17, 6'[1,3,4]тиадиазины, обладающие противовирусной активностью
CN115068681B (zh) *	2022-06-10	2023-06-13	中国人民解放军空军特色医学中心	一种具有骨细胞脱落功能的PNIPAAm-g-PDA修饰PCL骨支架及其制备方法
CN117003806B (zh) *	2023-07-18	2026-01-27	湖北大学	具有抗帕金森病活性的甾体化合物及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3094521A (en) *	1961-07-25	1963-06-18	Merck & Co Inc	Alkanoylthio and pyrazolo androstane derivatives
US3364207A (en) *	1962-08-13	1968-01-16	Searle & Co	Polyhydrospiro[estr/androst-4-ene-17, 2'-furan/pyran]-3-one and intermediates
US3300489A (en) *	1964-07-24	1967-01-24	Smith Kline French Lab	Steroidal c-17 spirolactones and processes and intermediates used in the preparation thereof
US3320242A (en) *	1964-11-12	1967-05-16	Parke Davis & Co	17beta, 20-epoxy steroids and methods for their production
US3413288A (en) *	1965-07-07	1968-11-26	Parke Davis & Co	Process for the production of steroidal c-17 spirolactones
GB1089788A (en) *	1965-07-07	1967-11-08	Parke Davis & Co	Process for the production of steroidal lactone compounds and intermediates thereof
US3364238A (en) *	1966-04-04	1968-01-16	Searle & Co	3-oxygenated spiro[androstene-17, 1'-cycloprop-2'-ene], 2', 3'-dihydro derivatives corresponding and intermediates thereto
US3365475A (en) *	1966-07-22	1968-01-23	Merck & Co Inc	Process for the preparation of 17alpha-(3'-hydroxy-propyl)-4-androstene-3beta, 17beta-diol
DE2237143A1 (de) *	1972-07-28	1974-02-14	Hoechst Ag	Verfahren zur herstellung von beta(3-keto-7alpha-acetylthio-17beta-hydroxy4-androsten-17alpha-yl)-propionsaeuregamma-lacton und dessen 1-dehydro-derivat
DE2349023A1 (de) *	1973-09-26	1975-04-10	Schering Ag	Neue d-homo-steroide
US3939155A (en) *	1974-06-28	1976-02-17	G. D. Searle & Co.	4',5'-Dihydrospiro[androst/estr-4-ene-17,2'(3'H)-furan]3,4'-dione and congeners, and intermediates thereto
US4054563A (en) *	1975-04-25	1977-10-18	Ciba-Geigy Corporation	Process for the manufacture of spiro compounds of the steroid series
FR2596395B1 (fr) *	1986-03-26	1989-05-26	Roussel Uclaf	Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US5556847A (en) *	1994-10-27	1996-09-17	Duquesne University Of The Holy Ghost	Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
WO1998005337A1 (en) *	1996-08-01	1998-02-12	Cocensys, Inc.	Use of gaba and nmda receptor ligands for the treatment of migraine headache
US5994334A (en) *	1997-02-05	1999-11-30	University Of Maryland	Androgen synthesis inhibitors
EP1310258A1 (en) *	2001-11-08	2003-05-14	Etienne-Emile Baulieu	Enantiomers of steroids for the enhancement of memory and cognitive function
WO2007103162A2 (en) *	2006-03-01	2007-09-13	Samaritan Pharmaceuticals, Inc.	Structure based drug design of steroidogenesis inhibitors

2007
- 2007-06-20 GB GBGB0711948.0A patent/GB0711948D0/en not_active Ceased
2008
- 2008-06-17 EP EP08762391.4A patent/EP2158209B1/en active Active
- 2008-06-17 WO PCT/GB2008/002067 patent/WO2008155534A2/en not_active Ceased
- 2008-06-17 AU AU2008265046A patent/AU2008265046C1/en active Active
- 2008-06-17 KR KR1020107001242A patent/KR101579323B1/ko active Active
- 2008-06-17 BR BRPI0813735-8A2A patent/BRPI0813735A2/pt not_active Application Discontinuation
- 2008-06-17 MX MX2009013189A patent/MX2009013189A/es active IP Right Grant
- 2008-06-17 EA EA201070027A patent/EA018632B1/ru unknown
- 2008-06-17 JP JP2010512762A patent/JP5698974B2/ja active Active
- 2008-06-17 CA CA2691071A patent/CA2691071C/en active Active
- 2008-06-17 US US12/665,569 patent/US9777037B2/en active Active
- 2008-06-17 CN CN200880021099.6A patent/CN101784558B/zh active Active
- 2008-06-17 MX MX2015008264A patent/MX355126B/es unknown
2009
- 2009-11-19 IL IL202223A patent/IL202223B/en active IP Right Grant
- 2009-11-20 ZA ZA2009/08215A patent/ZA200908215B/en unknown

Also Published As

Publication number	Publication date
EA018632B1 (ru)	2013-09-30
CN101784558B (zh)	2014-07-02
ZA200908215B (en)	2011-02-23
AU2008265046A1 (en)	2008-12-24
IL202223A0 (en)	2010-06-16
WO2008155534A9 (en)	2009-12-03
AU2008265046B2 (en)	2014-07-17
WO2008155534A2 (en)	2008-12-24
KR20100040292A (ko)	2010-04-19
US20100234335A1 (en)	2010-09-16
IL202223B (en)	2018-06-28
EA201070027A1 (ru)	2010-06-30
MX355126B (es)	2018-04-06
CA2691071A1 (en)	2008-12-24
CA2691071C (en)	2016-06-07
AU2008265046C1 (en)	2018-08-16
EP2158209B1 (en)	2019-02-27
JP5698974B2 (ja)	2015-04-08
CN101784558A (zh)	2010-07-21
WO2008155534A3 (en)	2009-04-09
EP2158209A2 (en)	2010-03-03
KR101579323B1 (ko)	2015-12-21
GB0711948D0 (en)	2007-08-01
US9777037B2 (en)	2017-10-03
JP2010530404A (ja)	2010-09-09
MX2009013189A (es)	2010-04-09

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-02-12	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI
2019-05-28	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-09-17	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-01-28	B09B	Patent application refused [chapter 9.2 patent gazette]
2020-11-17	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

Publication	Publication Date	Title
BRPI0813735A2 (pt)	2014-12-30	Compostos neuroesteróides
CY2024031I1 (el)	2026-02-25	Παραγωγο 4-πυριμιδινοσουλφαμιδης
BRPI0813500A2 (pt)	2015-01-06	Compostos antivirais
BRPI0821086A2 (pt)	2014-10-07	Compostos inseticidas
DK2185567T3 (da)	2011-05-16	Substituerede bicyclolactam-forbindelser
BRPI0815042A2 (pt)	2015-02-10	Compostos de pirazol
DK2288375T3 (da)	2012-05-21	Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt)	2015-12-29	compostos
DK2242759T3 (da)	2012-12-17	Forbindelser
EP2170350A4 (en)	2011-09-28	SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de)	2012-02-15	Substituierte piperidino-dihydrothienopyrimidine
BRPI0811264A2 (pt)	2014-11-04	Compostos
BRPI0809996A2 (pt)	2014-10-14	Compostos
SMT201600045B (it)	2016-02-25	Composti tetraciclinici c7-fluoro sostituiti
BRPI0814424A2 (pt)	2015-01-06	Compostos heterociclila
DK2297162T3 (da)	2012-11-26	Forbindelser
AT505058A3 (de)	2008-12-15	Türschliesssystem
BRPI0916432A2 (pt)	2016-02-16	compostos
BRPI0815181A2 (pt)	2015-03-31	Compostos
ATE546446T1 (de)	2012-03-15	5-aminocyclylmethyl-oxazolidin-2-eins-derivativ
DK2206698T3 (da)	2012-08-27	Ethynylindolforbindelser
BRPI0814613A2 (pt)	2015-01-27	Compostos
PL3825306T3 (pl)	2023-09-11	Związki morfinanu
BRPI0922152A2 (pt)	2015-08-18	Compostos
BRPI0922134A2 (pt)	2015-08-18	Compostos